Finanzwire Finanzwire
Basculer en Français
10370 Companies
216126 Keywords
145840 Articles
114440 Press releases
Headlines Articles Press releases NLS Pharmaceutics AG Remove
  1. Home
  2. Companies
  3. NLS Pharmaceutics AG
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • PRESS RELEASE

    published on 08/28/2023 at 13:30, 2 years 8 months ago

    NLS Pharmaceutics CEO Issues Letter to Shareholders

    Logo of NLS Pharmaceutics AG
  • PRESS RELEASE

    published on 05/02/2023 at 14:45, 3 years ago

    NLS Pharmaceutics Receives Green Light from the U.S. FDA to Proceed with Phase 3 Clinical Program (AMAZE) for Quilience(R) (Mazindol ER) for the Treatment of Narcolepsy

    Logo of NLS Pharmaceutics AG
  • PRESS RELEASE

    published on 03/27/2023 at 14:30, 3 years 1 month ago

    NLS Pharmaceutics Announces Open Label Extension Study Six-Month Data for Quilience(R) (Mazindol ER) in the Treatment of Narcolepsy Type 1 and Type 2

    Logo of NLS Pharmaceutics AG
  • PRESS RELEASE

    published on 01/23/2023 at 14:30, 3 years 3 months ago

    NLS Pharmaceutics Announces New In-Vitro Data Reconfirming Quilience's(R) (Mazindol ER) Unique Dual Mechanism of Action Involving Significant Orexin-2 Receptor Activity

    Logo of NLS Pharmaceutics AG
  • PRESS RELEASE

    published on 01/12/2023 at 14:30, 3 years 3 months ago

    NLS Pharmaceutics Announces an R&D Update Webcast to Review the Company's Growing Portfolio of Pre-Clinical Compounds

    Logo of NLS Pharmaceutics AG
Accesswire
  • Published on 05/08/2026 at 15:55, 1 hour 20 minutes ago

    Class 1 Nickel and Technologies Ltd. Announces Private Placement and Share for Debt Offering

  • Published on 05/08/2026 at 15:00, 2 hours 15 minutes ago

    Jaguar Health Regains Compliance with Nasdaq's Publicly Held Shares Requirement and Receives Additional Extension, Until May 18, 2026, to Demonstrate Compliance with Nasdaq's Bid Price Rule

  • Published on 05/08/2026 at 14:55, 2 hours 20 minutes ago

    Nepra Foods Inc. to Present at the 16th Annual LD Micro Invitational

  • Published on 05/08/2026 at 14:30, 2 hours 45 minutes ago

    Unusual Machines Hosts Live Drone Ecosystem Demonstrations at XPONENTIAL 2026

  • Published on 05/08/2026 at 14:00, 3 hours 15 minutes ago

    BlackBerry Announces Renewal of Normal Course Issuer Bid Share Buyback Program

View all ACCESSWIRE
EQS Group
  • Published on 05/08/2026 at 17:00, 14 minutes ago

    Drägerwerk AG & Co. KGaA: Dräger’s annual shareholders’ meeting resolves on a significant dividend increase

  • Published on 05/08/2026 at 16:35, 39 minutes ago

    Edison issues report on Canadian General Investments (CGI)

  • Published on 05/08/2026 at 16:15, 59 minutes ago

    Inaugural Global Mediation Summit boosts Hong Kong’s status as a global mediation hub

  • Published on 05/08/2026 at 16:15, 1 hour ago

    Lonza Announces Results of the 2026 Annual General Meeting – All Motions Proposed by Board of Directors Approved

  • Published on 05/08/2026 at 16:15, 1 hour ago

    DATAGROUP Acquires Dutch IT Service Provider Valid Managed Services

View all EQS
Les Echos
  • Published on 05/07/2026 at 19:15, 22 hours ago

    2026 Annual General Meeting: approval of all resolutions submitted to the Meeting

  • Published on 05/07/2026 at 19:06, 22 hours 8 minutes ago

    Disclosure of Share Capital and Voting Rights as of April 30, 2026

  • Published on 05/07/2026 at 18:17, 22 hours 58 minutes ago

    DESCRIPTION OF THE LOUIS HACHETTE GROUP SHARE BUYBACK PROGRAM 2026-2027

  • Published on 05/07/2026 at 18:12, 23 hours 2 minutes ago

    LNA SANTE : Q1 2026

  • Published on 05/07/2026 at 17:45, 23 hours 30 minutes ago

    MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy